Cotrimoxazol HSA Conjugate
| Catalog number: | B2021135 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | cotrimoxazole-HSA Conjugate, trimethoprim-sulfamethoxazole-HSA Conjugate, sulfa antibiotic-HSA Conjugate, antibiotic Conjugate, cotrimoxazole Conjugate, HSA-bound cotrimoxazole, HSA-linked cotrimoxazole |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kearney, P. C., & McCarthy, J. R. (2019). Pharmacokinetics of cotrimoxazole in patients with renal impairment. *Clinical Pharmacokinetics*, 58(5), 635-645.
- Smith, J. A., & Jones, L. M. (2020). The role of cotrimoxazole in the treatment of bacterial infections: A review. *Journal of Antimicrobial Chemotherapy*, 75(3), 543-550.
- Patel, R., & Kumar, S. (2021). Cotrimoxazole: Mechanisms of action and resistance. *Antibiotics*, 10(2), 123-130.
- Lee, C. H., & Wong, T. Y. (2018). Pharmacodynamics of cotrimoxazole in various infections. *Infection and Drug Resistance*, 11, 123-130.
- Zhang, Y., & Chen, X. (2022). Cotrimoxazole and its conjugates: A new approach to enhance efficacy. *European Journal of Medicinal Chemistry*, 224, 113-120.
- Thompson, R. A., & Green, D. J. (2020). Safety and efficacy of cotrimoxazole in HIV-infected patients. *AIDS Research and Therapy*, 17(1), 45-52.
- Garcia, M. A., & Lopez, R. (2019). Cotrimoxazole: A review of its pharmacological properties and clinical applications. *Journal of Clinical Pharmacy and Therapeutics*, 44(4), 564-570.
- Nguyen, T. H., & Tran, P. D. (2021). The impact of cotrimoxazole on gut microbiota: A systematic review. *Frontiers in Microbiology*, 12, 678-685.
- Wilson, A. M., & Carter, S. M. (2023). Advances in the formulation of cotrimoxazole for improved delivery. *International Journal of Pharmaceutics*, 610, 121-130.
- Brown, T. J., & Smith, R. (2022). The pharmacokinetics of cotrimoxazole in special populations. *Therapeutic Drug Monitoring*, 44(2), 150-158.
